Calls
1
Jacob Thaysen
CEO, Novo Nordisk
Win Rate
100.0%
return
+63.0%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 13
$146.99
+63.0%
Illumina ended 2025 with 7% ex-China Q4 growth and 15% full-year EPS growth despite sanctions, NIH funding pressure, and tariffs. China's ban on selling sequencers was removed and management sees a big growth opportunity once remaining unreliable-entity-list issues are resolved; NIH grant clarity should help academic customers over coming quarters.
Diagnostics
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Jacob Thaysen has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: ILMN.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
